Search results
Theseus (THRX) Up 57% in a Month on Strategic Restructuring Plan
Zacks via Yahoo Finance· 5 months agoTheseus (THRX) gains 57% in a month after announcing plans to conduct a process exploring strategic...
Theseus (THRX) Falls 72% on Decision to Discontinue GIST Study
Zacks via Yahoo Finance· 10 months agoTheseus (THRX) announces the discontinuation of enrollment in its phase I/II study of THE-630 in...
Theseus Pharmaceuticals (NASDAQ:THRX) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 7 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
What Makes Theseus Pharmaceuticals, Inc. (THRX) a New Buy Stock
Zacks via Yahoo Finance· 1 year agoTheseus Pharmaceuticals, Inc. (THRX) might move higher on growing optimism about its earnings...
Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth
Simply Wall St. via Yahoo Finance· 2 years agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Here's Why We're Not Too Worried About Theseus Pharmaceuticals' (NASDAQ:THRX) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 1 year agoJust because a business does not make any money, does not mean that the stock will go down. For...
After more than 6O years, is Cuba even Cuba anymore? | Opinion
Miami Herald via AOL· 2 years agoTheseus was the mythical king and founder of Athens. Many myths surrounding Theseus and his journeys...
What is the 'ship of Theseus' thought experiment?
Live Science via Yahoo News· 11 months agoThe Greek writer Plutarch proposed this question: If a ship's planks are replaced over time due to wear and tear until none of the original pieces...
Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – March 22, 2023 – Today, Zacks Equity Research discusses CRISPR...
Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies
Benzinga via Yahoo Finance· 1 year agoNeedham has initiated coverage on Theseus Pharmaceuticals Inc (NASDAQ: THRX) with a Buy rating and a...